NIP
PTLA

Nicholas Investment Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Nicholas Investment Partners’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-106,119
Closed -$4.01M – 258
2018
Q2 		$4.01M Buy
106,119
+66,629
+169% +$2.55M 0.28% 115
2018
Q1 		$1.29M Sell
39,490
-15,683
-28% -$688K 0.09% 213
2017
Q4 		$2.69M Sell
55,173
-8,832
-14% -$447K 0.18% 177
2017
Q3 		$3.46M Sell
64,005
-27,170
-30% -$1.6M 0.24% 142
2017
Q2 		$5.12M Sell
91,175
-375
-0.4% -$15K 0.36% 82
2017
Q1 		$3.59M Buy
91,550
+67,537
+281% +$2.15M 0.25% 140
2016
Q4 		$539K Buy
+24,013
New +$469K 0.04% 262
2016
Q3 		– Sell
-59,904
Closed -$1.41M – 338
2016
Q2 		$1.41M Buy
59,904
+6,158
+11% +$152K 0.1% 275
2016
Q1 		$1.1M Sell
53,746
-35,845
-40% -$1.14M 0.08% 280
2015
Q4 		$4.61M Buy
89,591
+20,884
+30% +$1.01M 0.32% 120
2015
Q3 		$2.93M Buy
68,707
+21,150
+44% +$1.02M 0.21% 201
2015
Q2 		$2.17M Sell
47,557
-15,184
-24% -$611K 0.14% 256
2015
Q1 		$2.38M Buy
62,741
+7,115
+13% +$244K 0.15% 245
2014
Q4 		$1.57M Buy
+55,626
New +$1.55M 0.1% 268

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nicholas Investment Partners's PTLA Position: Q3 2018 in Review

Nicholas Investment Partners sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2018, closing a stake of 106,119 shares — an estimated $4.01M sold.

Nicholas Investment Partners first reported a position in PTLA in Q4 2014 and held it in 14 quarters. The position peaked at $5.12M in Q2 2017. 197 funds tracked by Wall St. Rank hold PTLA as of Q3 2018.

  • Nicholas Investment Partners reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Nicholas Investment Partners sold 106,119 Portola Pharmaceuticals, Inc. shares in Q3 2018, an estimated $4.01M.
  • Nicholas Investment Partners first reported a position in Portola Pharmaceuticals, Inc. in Q4 2014 and held it in 14 quarters.
  • Nicholas Investment Partners's Portola Pharmaceuticals, Inc. position peaked at $5.12M in Q2 2017.
  • 197 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2018.

Based on Nicholas Investment Partners's 13F filing for Q3 2018, filed 14 Nov 2018.